Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093455 · ClinicalTrials.gov registry record · NA
Effects of Chardonnay Seed Flour on Vascular Health
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT02093455: Completed NA study, sponsored by Mayo Clinic.
NCT02093455 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 168 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02093455, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
This is a randomized, double-blinded trial (Chardonnay seed flour vs. placebo - in pill form) with the purpose to test the impact of a four-month supplementation with Chardonnay Seed Flour (CSF) on endothelial function. Chardonnay flour is made from wine grape skins and seeds. We will examine the effect of CSF on parameters such as endothelial function (via EndoPAT testing), plasma lipid levels, glucose tolerance, insulin resistance, inflammatory markers, oxidative stress surrogates, endothelial progenitor cells (EPCs) as well as the makeup of and impact on the gut microbiome (via stool samples).
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Chardonnay Seed Flour (CSF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093455
The ClinicalTrials.gov registry entry for NCT02093455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02093455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02093455 about?
NCT02093455 is a clinical study titled "Effects of Chardonnay Seed Flour on Vascular Health". This is a randomized, double-blinded trial (Chardonnay seed flour vs. placebo - in pill form) with the purpose to test the impact of a four-month supplementation with Chardonnay Seed Flour (CSF) on endothelial function. Chardonnay flour is made from wine grape skins and seeds. We will examine the ef...
What is the current status of trial NCT02093455?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2014-03. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02093455?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Chardonnay Seed Flour (CSF) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02093455?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.